🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 3, randomized, double-blind, placebo-controlled study to ev...
Status
Completed
Location
Neurocrine Clinical Site
Start Date
2019-11-13
Trial ID
NCT04102579
Treatments Being Tested
The goal of this open-label clinical trial is to test the safety and effica...
Status
Withdrawn
Location
University Hospitals of Cleveland
Start Date
2025-01
Trial ID
NCT06107829
Treatments Being Tested
This is a Phase 2, double-blind, placebo-controlled, randomized withdrawal ...
Status
Terminated
Location
Neuricrine Clinical Site
Start Date
2018-04-17
Trial ID
NCT03530293
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02274558
This is a Phase 3, open-label study to evaluate the long-term safety and to...
Status
Completed
Location
Neurocrine Clinical Site
Start Date
2020-09-18
Trial ID
NCT04400331
Treatments Being Tested
This is a Phase 4, randomized, double-blind, placebo-controlled study to ev...
Status
Completed
Location
Neurocrine Clinical Site
Start Date
2018-09-14
Trial ID
NCT03698331
Treatments Being Tested
This is a Phase 4, randomized, double-blind, placebo-controlled study to ev...
Status
Completed
Location
Neurocrine Clinical Site
Start Date
2019-03-18
Trial ID
NCT03891862
Treatments Being Tested
This study will evaluate long-term safety and tolerability of valbenazine i...
Status
Enrolling By Invitation
Location
Neurocrine Clinical Site
Start Date
2024-04-24
Trial ID
NCT06312189
Treatments Being Tested
This study will evaluate the effectiveness of valbenazine on patient- and c...
Status
Completed
Location
Neurocrine Clinical Site
Start Date
2023-05-09
Trial ID
NCT05859698
Treatments Being Tested
This study will evaluate the efficacy of valbenazine on clinician- and pati...
Status
Recruiting
Location
Neurocrine Clinical Site
Start Date
2025-08-29
Trial ID
NCT07105111
Treatments Being Tested